Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)

NCT03620838 is registered in ClinicalTrials.gov with Uludag University as lead sponsor.

NCT NCT03620838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Lead sponsor
Uludag University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
September 1, 2020
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma, ovarian reserve